Clinical utility of the HFA-ICOS risk tool in real-world HER2-positive breast cancer patients receiving therapy
{{output}}
Background: The HFA-ICOS baseline cardiovascular risk stratification framework is widely recommended to guide surveillance in patients receiving potentially cardiotoxic cancer therapies, yet real-world evidence supporting its cli... ...
